298 related articles for article (PubMed ID: 21323961)
21. Fibronectin expression in salivary gland pleomorphic adenoma.
Luo M; Takagi H; Tsubone M; Ando C; Ogata K; Shrestha P; Mori M
Arch Anat Cytol Pathol; 1993; 41(2):68-74. PubMed ID: 8239749
[TBL] [Abstract][Full Text] [Related]
22. Malignant disease of the minor oral salivary glands.
DelBalso AM
Otolaryngol Clin North Am; 1979 Feb; 12(1):135-40. PubMed ID: 220580
[No Abstract] [Full Text] [Related]
23. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma.
Soares CD; de Lima Morais TM; Carlos R; Martins MD; de Almeida OP; Mariano FV; Altemani A
Hum Pathol; 2019 Oct; 92():59-66. PubMed ID: 31400353
[TBL] [Abstract][Full Text] [Related]
24. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
[TBL] [Abstract][Full Text] [Related]
25. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome.
Sedassari BT; Rodrigues MFSD; Conceição TS; Mariano FV; Alves VAF; Nunes FD; Altemani A; de Sousa SCOM
Virchows Arch; 2017 Dec; 471(6):775-784. PubMed ID: 28842747
[TBL] [Abstract][Full Text] [Related]
26. Aberrant protein expression and promoter methylation of p16 gene are correlated with malignant transformation of salivary pleomorphic adenoma.
Hu YH; Zhang CY; Tian Z; Wang LZ; Li J
Arch Pathol Lab Med; 2011 Jul; 135(7):882-9. PubMed ID: 21732778
[TBL] [Abstract][Full Text] [Related]
27. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.
Di Palma S
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S68-76. PubMed ID: 23821206
[TBL] [Abstract][Full Text] [Related]
28. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.
Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A
Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188
[TBL] [Abstract][Full Text] [Related]
29. Immunoprofile of reactive salivary myoepithelial cells in intraductal areas of carcinoma ex-pleomorphic adenoma.
de Araújo VC; Altemani A; Furuse C; Martins MT; de Araújo NS
Oral Oncol; 2006 Nov; 42(10):1011-6. PubMed ID: 16757205
[TBL] [Abstract][Full Text] [Related]
30. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
31. Recurrent mixed tumor (pleomorphic adenoma) of the palate: A case report.
North AF; Levin LS; Hansen LS
J Md State Dent Assoc; 1984 Aug; 27(2):76-8. PubMed ID: 6098623
[No Abstract] [Full Text] [Related]
32. [The relationship of abnormal expression of cell glucoprotein with recurrence of pleomorphic adenoma in salivary gland].
Gao P; Zhou GY; Song XR; Hou JX; Zhang CJ; Ma C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2005 Apr; 23(2):164-6. PubMed ID: 15952635
[TBL] [Abstract][Full Text] [Related]
33. Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.
Hamada T; Matsukita S; Goto M; Kitajima S; Batra SK; Irimura T; Sueyoshi K; Sugihara K; Yonezawa S
J Clin Pathol; 2004 Aug; 57(8):813-21. PubMed ID: 15280401
[TBL] [Abstract][Full Text] [Related]
34. Histogenic classification of salivary tumors.
Eversole LR
Arch Pathol; 1971 Dec; 92(6):433-43. PubMed ID: 4330584
[No Abstract] [Full Text] [Related]
35. Upregulation of Igf and Wnt signalling associated genes in pleomorphic adenomas of the salivary glands in PLAG1 transgenic mice.
Declercq J; Van Dyck F; Van Damme B; Van de Ven WJ
Int J Oncol; 2008 May; 32(5):1041-7. PubMed ID: 18425330
[TBL] [Abstract][Full Text] [Related]
36. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
[TBL] [Abstract][Full Text] [Related]
37. [A case of very late malignant degeneration of pleomorphic adenoma].
Darche V; Hustin J; Lejuste P; Robillard T; Piette E
Ann Otolaryngol Chir Cervicofac; 1998 Dec; 115(6):373-7. PubMed ID: 9922836
[TBL] [Abstract][Full Text] [Related]
38. [The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma].
Chen Y; Tian K; Geng N; Yang MZ; Zhang WP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan; 40(1):58-61. PubMed ID: 15774155
[TBL] [Abstract][Full Text] [Related]
39. Metastatic benign pleomorphic adenoma. Report of a case and review of the literature.
Rodríguez-Fernández J; Mateos-Micas M; Martínez-Tello FJ; Berjón J; Montalvo JJ; Forteza-González G; Galan-Hernández R
Med Oral Patol Oral Cir Bucal; 2008 Mar; 13(3):E193-6. PubMed ID: 18305442
[TBL] [Abstract][Full Text] [Related]
40. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.
Katori H; Nozawa A; Tsukuda M
Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
